US Biosimilars Will Get Regulatory Science Program, Supplement Timeline Changes In Next User Fee Agreement

 
• By Derrick Gingery
  
Sign outside of FDA's headquarters in White Oak, MD
The completed BsUFA III agreement includes supplement timeline improvements
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products